p53 protein expression affected by TP53 polymorphism is associated with the biological behavior and prognosis of low rectal cancer

Zhang,Guangzhe; Xu,Qian; Wang,Zeyang; Sun,Liping; Lv,Zhi; Liu,Jingwei; Xing,Chengzhong; Yuan,Yuan

doi:10.3892/ol.2019.10999

p53 protein expression affected by TP53 polymorphism is associated with the biological behavior and prognosis of low rectal cancer

Authors:
- Guangzhe Zhang
- Qian Xu
- Zeyang Wang
- Liping Sun
- Zhi Lv
- Jingwei Liu
- Chengzhong Xing
- Yuan Yuan
View Affiliations

Affiliations: Department of Tumor Etiology and Screening, Cancer Institute and General Surgery, The First Hospital of China Medical University, Shenyang, Liaoning 110001, P.R. China
Published online on: October 18, 2019 https://doi.org/10.3892/ol.2019.10999
Pages: 6807-6821

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

Low rectal cancer is a subtype of colorectal cancer at a special anatomic site with distinct biological behavior. TP53 is one of the most important cancer suppressor genes, and its structural variation and abnormal expression has been revealed to be associated with multiple cancer types. However, to the best of our knowledge, the association of p53 protein expression with its gene polymorphism, biological behavior and prognosis in low rectal cancer has not been clarified. Therefore, the current study aimed to explore these associations. In the present study, 347 patients with low rectal cancer and 353 controls were enrolled. Kompetitive Allele‑Specific Polymerase Chain Reaction was used to detect five polymorphic sites of the TP53 gene (rs1042522, rs12947788, rs1625895, rs2909430 and rs12951053), while immunohistochemistry was used to detect the protein expression of TP53. The associations between p53 protein expression and TP53 polymorphism, biological behavior and prognosis in low rectal cancer were systematically analyzed. In low rectal cancer, p53 protein expression was markedly higher in TP53 rs1042522 mutant carriers compared with that in other genotypes where expression was higher in poorly differentiated, III‑IV phase and T3‑4 phase tumors, and in III‑IV phase female patients. The survival time of patients with low p53 protein expression was evidently longer in females, non‑smokers and patients >60 years old. In summary, p53 protein expression was identified to be affected by TP53 rs1042522 polymorphism, and was associated with the biological behavior and prognosis of low rectal cancer. TP53 rs1042522 and the associated protein expression could be used as indicators for biological behavior and prognosis in low rectal cancer.

View Figures

View References

1	Pachler J and Wille-Jørgensen P: Quality of life after rectal resection for cancer, with or without permanent colostomy. Cochrane Database Syst Rev. 12:CD0043232012.PubMed/NCBI
2	Sarver AL, Li L and Subramanian S: MicroRNA miR-183 functions as an oncogene by targeting the transcription factor EGR1 and promoting tumor cell migration. Cancer Res. 70:9570–9580. 2010. View Article : Google Scholar : PubMed/NCBI
3	Liu Y, Zhang H, Zhou K, Chen L, Xu Z, Zhong Y, Liu H, Li R, Shugart YY, Wei Q, et al: Tagging SNPs in non-homologous end-joining pathway genes and risk of glioma. Carcinogenesis. 28:1906–1913. 2007. View Article : Google Scholar : PubMed/NCBI
4	Liu Y, Zhou K, Zhang H, Shugart YY, Chen L, Xu Z, Zhong Y, Liu H, Jin L, Wei Q, et al: Polymorphisms of LIG4 and XRCC4 involved in the NHEJ pathway interact to modify risk of glioma. Hum Mutat. 29:381–389. 2008. View Article : Google Scholar : PubMed/NCBI
5	Liu Y, Shete S, Etzel CJ, Scheurer M, Alexiou G, Armstrong G, Tsavachidis S, Liang FW, Gilbert M, Aldape K, et al: Polymorphisms of LIG4, BTBD2, HMGA2, and RTEL1 genes involved in the double-strand break repair pathway predict glioblastoma survival. J Clin Oncol. 28:2467–2474. 2010. View Article : Google Scholar : PubMed/NCBI
6	Soussi T and Béroud C: Assessing TP53 status in human tumours to evaluate clinical outcome. Nat Rev Cancer. 1:233–240. 2001. View Article : Google Scholar : PubMed/NCBI
7	Bénard J, Douc-Rasy S and Ahomadegbe JC: TP53 family members and human cancers. Hum Mutat. 21:182–191. 2003. View Article : Google Scholar : PubMed/NCBI
8	Li D, Suzuki H, Liu B, Morris J, Liu J, Okazaki T, Li Y, Chang P and Abbruzzese JL: DNA repair gene polymorphisms and risk of pancreatic cancer. Clin Cancer Res. 15:740–746. 2009. View Article : Google Scholar : PubMed/NCBI
9	Liu H and Zhou M: Evaluation of p53 gene expression and prognosis characteristics in uveal melanoma cases. Onco Targets Ther. 10:3429–3434. 2017. View Article : Google Scholar : PubMed/NCBI
10	Chava S, Mohan V, Shetty PJ, Manolla ML, Vaidya S, Khan IA, Waseem GL, Boddala P, Ahuja YR and Hasan Q: Immunohistochemical evaluation of p53, FHIT, and IGF2 gene expression in esophageal cancer. Dis Esophagus. 25:81–87. 2012. View Article : Google Scholar : PubMed/NCBI
11	Vogelstein B, Lane D and Levine AJ: Surfing the p53 network. Nature. 408:307–310. 2000. View Article : Google Scholar : PubMed/NCBI
12	Tefre T, Ryberg D, Haugen A, Nebert DW, Skaug V, Brøgger A and Børresen AL: Human CYP1A1 (cytochrome P (1)450) gene: Lack of association between the Msp I restriction fragment length polymorphism and incidence of lung cancer in a Norwegian population. Pharmacogenetics. 1:20–25. 1991. View Article : Google Scholar : PubMed/NCBI
13	Slattery ML, Samowtiz W, Ma K, Murtaugh M, Sweeney C, Levin TR and Neuhausen S: CYP1A1, cigarette smoking, and colon and rectal cancer. Am J Epidemiol. 160:842–852. 2004. View Article : Google Scholar : PubMed/NCBI
14	Kiyohara C, Washio M, Horiuchi T, Asami T, Ide S, Atsumi T, Kobashi G, Takahashi H and Tada Y; Kyushu Sapporo SLE (KYSS) Study Group, : Risk modification by CYP1A1 and GSTM1 polymorphisms in the association of cigarette smoking and systemic lupus erythematosus in a Japanese population. Scand J Rheumatol. 41:103–109. 2012. View Article : Google Scholar : PubMed/NCBI
15	Goodman JE, Mechanic LE, Luke BT, Ambs S, Chanock S and Harris CC: Exploring SNP-SNP interactions and colon cancer risk using polymorphism interaction analysis. Int J Cancer. 118:1790–1797. 2006. View Article : Google Scholar : PubMed/NCBI
16	Tan XL, Nieters A, Hoffmeister M, Beckmann L, Brenner H and Chang-Claude J: Genetic polymorphisms in Tp53, nonsteroidal anti-inflammatory drugs and the risk of colorectal cancer: Evidence for gene-environment interaction? Pharmacogenet Genomics. 17:639–645. 2007. View Article : Google Scholar : PubMed/NCBI
17	Li XL, Zhou J, Chen ZR and Chng WJ: P53 mutations in colorectal cancer-molecular pathogenesis and pharmacological reactivation. World J Gastroenterol. 21:84–93. 2015. View Article : Google Scholar : PubMed/NCBI
18	Kahlenberg MS, Stoler DL, Rodriguez-Bigas MA, Weber TK, Driscoll DL, Anderson GR and Petrelli NJ: p53 tumor suppressor gene mutations predict decreased survival of patients with sporadic colorectal carcinoma. Cancer. 88:1814–1819. 2000. View Article : Google Scholar : PubMed/NCBI
19	Mulder JW, Baas IO, Polak MM, Goodman SN and Offerhaus GJ: Evaluation of p53 protein expression as a marker for long-term prognosis in colorectal carcinoma. Br J Cancer. 71:1257–1262. 1995. View Article : Google Scholar : PubMed/NCBI
20	Erhan Y, Korkut MA, Kara E, Aydede H, Sakarya A and Ilkgü O: Value of p53 protein expression and its relationship with short-term prognosis in colorectal cancer. Ann Saudi Med. 22:377–380. 2002. View Article : Google Scholar : PubMed/NCBI
21	Glimelius B, Tiret E, Cervantes A and Arnold D; ESMO Guidelines Working Group, : Rectal cancer: ESMO clinical practice guidelines for diagnosis, treatment and follow-up. Ann Oncol. 24 (Suppl 6):vi81–vi88. 2013. View Article : Google Scholar : PubMed/NCBI
22	Albibas AA, Rose-Zerilli MJJ, Lai C, Pengelly RJ, Lockett GA, Theaker J, Ennis S, Holloway JW and Healy E: Subclonal evolution of cancer-related gene mutations in p53 immunopositive patches in human skin. J Invest Dermatol. 138:189–198. 2018. View Article : Google Scholar : PubMed/NCBI
23	Duffy MJ, Synnott NC and Crown J: Mutant p53 as a target for cancer treatment. Eur J Cancer. 83:258–265. 2017. View Article : Google Scholar : PubMed/NCBI
24	Jen J, Lin LL, Lo FY, Chen HT, Liao SY, Tang YA, Su WC, Salgia R, Hsu CL, Huang HC, et al: Oncoprotein ZNF322A transcriptionally deregulates alpha-adducin, cyclin D1 and p53 to promote tumor growth and metastasis in lung cancer. Oncogene. 36:52192017. View Article : Google Scholar : PubMed/NCBI
25	Chaudhary R, Gryder B, Woods WS, Subramanian M, Jones MF, Li XL, Jenkins LM, Shabalina SA, Mo M, Dasso M, et al: Prosurvival long noncoding RNA PINCR regulates a subset of p53 targets in human colorectal cancer cells by binding to Matrin 3. Elife. 6(pii): e232442017. View Article : Google Scholar : PubMed/NCBI
26	Jiang Z, Hennein L, Xu Y, Bao N, Coh P and Tao L: Elevated serum monocyte chemoattractant protein-1 levels and its genetic polymorphism is associated with diabetic retinopathy in Chinese patients with type 2 diabetes. Diabet Med. 33:84–690. 2016. View Article : Google Scholar : PubMed/NCBI
27	Zlotorynski E: Cancer biology: A Neat target of p53. Nat Rev Mol Cell Biol. 18:5322017. View Article : Google Scholar : PubMed/NCBI
28	Boiocchi C, Osera C, Monti MC, Ferraro OE, Govoni S, Cuccia M, Montomoli C, Pascale A and Bergamaschi R: Are Hsp70 protein expression and genetic polymorphism implicated in multiple sclerosis inflammation? J Neuroimmunol. 268:84–88. 2014. View Article : Google Scholar : PubMed/NCBI
29	Yao C, Li G, Cai M, Qian Y, Wang L, Xiao L, Thaiss F and Shi B: Expression and genetic polymorphism of necroptosis related protein RIPK1 is correlated with severe hepatic ischemia-reperfusion injury and prognosis after hepatectomy in hepatocellular carcinoma patients. Cancer Biomark. 20:23–29. 2017. View Article : Google Scholar : PubMed/NCBI
30	Naccarati A, Polakova V, Pardini B, Vodickova L, Hemminki K, Kumar R and Vodicka P: Mutations and polymorphisms in TP53 gene-an overview on the role in colorectal cancer. Mutagenesis. 27:211–218. 2012. View Article : Google Scholar : PubMed/NCBI